New Hope Network is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

NattoPharma names Badmaev head of R&D

NattoPharma names Badmaev head of R&D
Prior to appointment with NattoPharma, Dr. Badmaev served as a vice president of Sabinsa and medical and scientific director of PLThomas.

NattoPharma hired Dr. Vladimir Badmaev to lead research and product development program to support its premium brand of vitamin K2, MenaQ7, and also head the development of a line of biotechnology products based on fermentation technologies and a solvent-free green technology to broaden the food, nutraceutical and pharmaceutical applications of NattoPharma products.

“Dr. Badmaev is a much welcome addition to the NattoPharma team,” stated NattoPharma Executive Chairman Frode Bohan. “He has pioneered many leading ingredients in the natural products industry in his career, and his proven record of guiding product development will surely help us grow our Vitamin K2 franchise, as well as creating additional product offerings as we expand our biotechnology base.”

Dr. Badmaev received his MD and PhD (Immunopharmacology) in Bialystok, Poland and training in clinical and anatomical pathology at Kings County Hospital and Downstate Medical Center, New York (1982-1985). He is the author/coauthor of over 70 scientific and popular scientific articles, 13 books, 13 US and International patents and 9 successful IND applications with the FDA, several self-affirmed GRAS documents and NDI applications.

Recently, in a joint venture with a group of international investors he established American Medical Holdings, Inc., dedicated to developing natural and synthetic pharmaceuticals which he terms “Interactive nutrients.”

Dr. Badmaev is the 2004 recipient of the New Jersey R&D Council Thomas Alva Edison Award in 2004 for ForsLean, an ingredient promoting Lean Body Mass. He is the 2005 recipient of the Award for Bioperine in promoting nutrient bioavailability and the 2009 recipient of Thomas Alva Edison Award for composition of Garcitrin natural and synthetic HCA for body weight management. Dr. Badmaev participated in the following Medical/Scientific Societies: International Society of Immunopharmacology (1982), American Association of Clinical Pathologists (1983), American Medical Association (1984), Research and Development Council of New Jersey (1996).

The lifelong goal of Dr. Badmaev is to develop complementary and pharmaceutical treatments derived from traditional medical systems as a permanent element in the health care education and health care system in the West. In keeping with this theme, in 2009 Dr. Badmaev contributed a chapter on curcuminoids (C3Complex) in Raymond Cooper’s and Fredi Kronenberg’s book for health professionals titled “Botanical Medicine: From Bench to Bedside.” Dr. Badmaev published a book on Tibetan medicine entitled “Healing Herbs” describing efforts of five generations of physicians in his family in bringing Tibetan medicine as practiced in Baikal region of Russia to the West. In 1999 he contributed a chapter on Tibetan medicine in Wayne Jonas’s and Jeffrey Levine’s textbook for medical students and health professionals titled “Essentials of Alternative and Complementary Medicine” – published by Williams & Wilkins and Lippincott.

Prior to appointment with NattoPharma Dr. Badmaev has successfully served as a VP and Medical and Scientific Director with Sabinsa Inc. and PLThomas Inc. respectively, assisting those companies in building pre-clinical and clinical research on the innovative standardized food supplements. Dr. Badmaev will continue in his role as advisor to PLThomas Inc.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.